4//SEC Filing
Went Gregory T 4
Accession 0001209191-19-020763
CIK 0001328143other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 4:37 PM ET
Size
6.0 KB
Accession
0001209191-19-020763
Insider Transaction Report
Form 4
Went Gregory T
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
2019-03-20$7.99/sh−6,319$50,489→ 176,291 total
Holdings
- 199,242(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units.
- [F2]The shares were sold at prices ranging from $7.94 to $8.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeother
Related Parties
1- filerCIK 0001604541
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 4:37 PM ET
- Size
- 6.0 KB